L'uso del dispositivo vasculare totalmente impiantato (TIVAD) e le complicate tardive. Un'analisi retrospettiva

The totally implanted vascular access device (TIVAD) entered in the routine clinical care in oncology. This device, compared with external central venous catheters, offers some important advantages, but some complications may occur. Methods: From I November 2004 to 30^th November 2007, 302 records of cancer outpatients with Port have been studied in the Oncology Department of Biella. In these patients 305 devices were placed. Results: 61.6 % of the 305 devices were placed into a subclavian vein, 2.7% in the jugular vein. A total of 22 complications were recorded: 4 total occlusions (1.3%), 2 infections (0.7%), 6 venous thrombosis (2%), 10 other complications (extravasation, catheter kinking, fibrin sheath, damage and dislocation). Discussion: In patients with totally implanted vascular access devices some complications may occur. In our experience thrombosis is the most frequent. The appropriate nursing management is important to reduce the TIVAD complications, improving patient satisfaction and safety.